Application 204268

Type
ANDA
Sponsor
PERRIGO ISRAEL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TESTOSTERONETESTOSTERONEGEL, METERED;TRANSDERMAL1.62% (20.25MG/1.25GM ACTUATION)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-967testosteronetestosteroneNorthstar Rx LLCANDACurrent
16714-967testosteronetestosteroneNorthstar RxLLCANDACurrent
16714-967testosteronetestosteroneNorthstar RxLLCANDACurrent
16714-967testosteronetestosteroneNorthstar RxLLCANDACurrent
45802-754testosteronetestosteronePerrigo New York IncANDACurrent
45802-754testosteronetestosteronePerrigo New York IncANDACurrent
45802-754testosteronetestosteronePadagis Israel Pharmaceuticals LtdANDACurrent
45802-754testosteronetestosteronePerrigo New York IncANDACurrent
45802-754testosteronetestosteronePerrigo New York IncANDACurrent
63629-8455testosteronetestosteroneBryant Ranch PrepackANDACurrent
63629-8455testosteronetestosteroneBryant Ranch PrepackANDACurrent
63629-8455testosteronetestosteroneBryant Ranch PrepackANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
24121ORIG2015-08-14
10314ORIG2015-08-06